Coppel Family
1
116M
1
1
- Areas of investment
Summary
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Coppel Family, startups are often financed by dievini Hopp Biotech Holding, Bill & Melinda Gates Foundation. The meaningful sponsors for the fund in investment in the same round are dievini Hopp Biotech Holding, Sigma Group, Northview LifeSciences. In the next rounds fund is usually obtained by Landeskreditbank Baden-Wu00fcrttemberg, LBBW Asset Management, Baden-Wu00fcrttembergische Versorgungsanstalt fu00fcr u00c4rzte.
We can highlight the next thriving fund investment areas, such as Therapeutics, Biopharma. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight CureVac.
The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of more than 100 millions dollars. The typical startup value when the investment from Coppel Family is more than 1 billion dollars. The high activity for fund was in 2015.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Therapeutics (1)
- Biopharma (1)
- Biotechnology (1)
- Investments by region
-
- Germany (1)
- Peak activity year
- 2015
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 1B
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.